Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $660.2 million.

  • Ironwood Pharmaceuticals' Total Liabilities fell 579.78% to $660.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $660.2 million, marking a year-over-year decrease of 579.78%. This contributed to the annual value of $652.2 million for FY2024, which is 2020.2% down from last year.
  • As of Q3 2025, Ironwood Pharmaceuticals' Total Liabilities stood at $660.2 million, which was down 579.78% from $651.1 million recorded in Q2 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' Total Liabilities peaked at $950.0 million during Q2 2023, and registered a low of $442.8 million during Q2 2022.
  • Moreover, its 5-year median value for Total Liabilities was $651.1 million (2025), whereas its average is $620.5 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first skyrocketed by 11453.97% in 2023, then plummeted by 2448.96% in 2024.
  • Over the past 5 years, Ironwood Pharmaceuticals' Total Liabilities (Quarter) stood at $521.0 million in 2021, then fell by 13.99% to $448.1 million in 2022, then surged by 82.39% to $817.4 million in 2023, then dropped by 20.2% to $652.2 million in 2024, then grew by 1.22% to $660.2 million in 2025.
  • Its Total Liabilities was $660.2 million in Q3 2025, compared to $651.1 million in Q2 2025 and $661.3 million in Q1 2025.